Bio-Techne Corp. vs Johnson & Johnson
TECH vs JNJ — side-by-side comparison from reported financials. TECH leads 1, JNJ leads 10 of 11 comparable metrics.
Bio-Techne Corp.
TECH · Healthcare
$72.44-0.01%Strong
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | TECH | JNJ |
|---|---|---|
| Price | $72.44 | $261.79 |
| Market cap | $11.4B | $631B |
| Revenue (TTM) | $1.22B | $97.9B |
| Revenue growth | +2.3% | +5.6% |
| Net margin | 15.0% | 21.5% |
| Free cash flow | $263M | $22.2B |
| Net cash (debt) | ($23.6M) | ($27.8B) |
| 1-year price return | +20.9% | +37.0% |
| P/E | 62.5 | 29.9 |
| P/E vs own history (cheap-side %) | 14% | 16% |
| Dividend yield | 0.44% | 2.00% |
| Return on equity | 9% | 26% |
| Altman Z-score | 15.94 | — |
| CV checks passed | 8 of 11 | 10 of 11 |
| Employees | 3,000 | 140,800 |
Full résumé-style profiles: TECH CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.